Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RELAX-AHF Phase II/III trial of relaxin in acute heart failure
2007-004271-19Phase 3Completed
- Sponsor
- Novartis
- Start
- Nov 2007
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of Relaxin in Acute Heart Failure (AHF), sponsored by Novartis. Started Nov 2007; status: completed.
02
Drugs
Relaxin
03
Conditions
Acute Heart Failure (AHF)
Beyond the preview
Go deeper on 2007-004271-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-004271-19.